Treceți offline cu aplicația Player FM !
Is HER2 targeting on the horizon for urothelial carcinoma?
Manage episode 397347959 series 3389426
touchFOCUS for touchONCOLOGY
A genitourinary medical oncologist considers the potential for targeting HER2 in the treatment of urothelial carcinoma, including the rationale for HER2 as a target, approaches to HER2 testing, the latest data on emerging HER2-targeted therapies and the potential implications for future clinical practice.
The expert:
- Dr Vadim Koshkin - University of California San Francisco, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Seagen Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncology.com
102 episoade
Manage episode 397347959 series 3389426
touchFOCUS for touchONCOLOGY
A genitourinary medical oncologist considers the potential for targeting HER2 in the treatment of urothelial carcinoma, including the rationale for HER2 as a target, approaches to HER2 testing, the latest data on emerging HER2-targeted therapies and the potential implications for future clinical practice.
The expert:
- Dr Vadim Koshkin - University of California San Francisco, CA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Seagen Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncology.com
102 episoade
Toate episoadele
×Bun venit la Player FM!
Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.